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INTRODUCTION
This report describes key challenges and successes of a federally-funded, cross-organizational effort to
use registry data from the State of Maine’s Immunization Information System to calculate childhood and
adolescent immunization measures in support of a nine-month, multi-practice learning collaborative
which resulted in significant increases in immunization rates and adoption of recommended
immunization-related office system procedures. Also highlighted are lessons learned about promoting
the use of standardized immunization measures for quality improvement (QI), supporting primary care
practices in using and understanding data for QI activities, and emphasizing the value of public-private
collaboration in achieving shared goals.

BACKGROUND
As mandated by section 401(d) of the Child Health Insurance Program Reauthorization Act (CHIPRA) of
2009, the Centers for Medicare and Medicaid Services (CMS) released the Initial Core Set of Children’s
Health Care Quality Measures in 2010. Under this legislation, CMS also established the Pediatric Quality
Measures Program (PMQP) whose charge it is to improve and strengthen the Initial Core Set; expand on
and advance the development of existing pediatric quality measures used by public and private payers;
and increase the portfolio of evidenced-based pediatric quality measures available to public and private
payers, consumers, and providers.1 After several revisions since its release in 2010, the Initial Core Set is
now titled the CHIPRA Core Set of Children’s Health Care Quality Measures. The CHIPRA Core Set is a
collection of standardized, evidence-based measures which CMS has invited States to voluntarily report
on as a component of the CHIP Annual Reporting Template System (CARTS)—a web-based reporting
system that CMS and its contractors use to monitor the operations of State Medicaid and CHIP
programs.
Also in 2010, the Office of MaineCare Services (Maine’s Medicaid and CHIP program) at the State of
Maine’s Department of Health and Human Services was awarded a five-year CHIPRA Quality
Demonstration Grant in partnership with Maine’s Center for Disease Control and Prevention, the Muskie
School of Public Service at the University of Southern Maine, the Department of Vermont Health Access
(Vermont’s Medicaid program), and the University of Vermont. According to CMS, the CHIPRA Quality
Demonstration Grant Program funds States to test promising ideas for improving the quality of
children’s health care provided under Medicaid and CHIP programs with a specific aim of identifying
“effective, replicable strategies for enhancing quality of care for children.”2 A total of 10 grants were
awarded to 18 states that are implementing a variety of projects under one or more of five grant
categories, listed below:
•
•
•
•
•

Category A: Using quality measures to improve child health care
Category B: Applying health information technology for quality improvement
Category C: Implementing provider-based delivery models
Category D: Investigating a model format for Pediatric electronic health records (EHRs)
Category E: Assessing the utility of other innovative approaches to enhance quality
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Known as Improving Health Outcomes for Children (IHOC), Maine’s CHIPRA grant conducts multiple
projects under Categories A, B, and C with an overarching objective to test methods for collecting and
reporting measures from the CHIPRA Core Set in support of quality reporting and practice improvement
efforts. A brief description of IHOC’s work by grant category is presented in Table 1. The subject of this
report is IHOC’s cross-category pilot to test data collection and reporting of practice-level CHIPRA
immunization measures in support of the first phase of a multi-practice quality improvement initiative
funded through IHOC called First STEPS (Strengthening Together Early and Periodic Screening).

Table 1. Maine’s CHIPRA Quality Demonstration Grant by Category
Improving Health Outcomes for Children (IHOC)
CATEGORY A

IHOC staff from the University of Southern Maine’s Muskie School of Public Service are
testing the calculation and reporting of CHIPRA Initial Core Set measures. This work includes
analyzing data and producing rates for measures with existing data sources; identifying and
testing new methods for calculating rates for measures without existing data sources; and
communicating challenges, potential solutions, and progress to CMS and child health
stakeholders.

CATEGORY B

IHOC’s Health Information Technology (HIT) Team includes staff from the Muskie School,
Maine Quality Counts, the Office of Information Technology at Maine’s Department of Health
and Human Services, and the state’s Health Information Exchange (HealthInfoNet). The IHOC
HIT Team coordinates multiple cross-organizational activities in support of IHOC’s measure
reporting and practice improvement initiatives. A primary focus of this work is the design,
development, and testing of electronic methods to calculate and report child health
measures using data sources and environments including the electronic health record (EHR);
MaineCare claims and eligibility data systems; Maine’s Health Information Exchange
(HealthInfoNet); and the state’s immunization information system (ImmPact).

CATEGORY C

IHOC’s Category C team is led by the Director of Child Health Quality Improvement at Maine
Quality Counts—an independent healthcare collaborative with a focus on quality
improvement—with support from additional staff at Quality Counts and the Muskie School.
Maine Quality Counts develops and implements the First STEPS (Strengthening Together Early
Preventive Services) Learning Collaborative and the Maine Child Health Improvement
Partnership (ME CHIP). The mission of ME CHIP is “To optimize the health of Maine children
by initiating and supporting measurement-based efforts to enhance child health care by
fostering public/private partnerships” towards a vision that “All practices providing health
care to children will have the skills, support, and opportunities for collaborative learning
needed to deliver high quality health care.” (From
http://www.mainequalitycounts.org/page/2-700/mechip-documents).

Based on the Institute for Healthcare Improvement’s (IHI) learning collaborative model, First STEPS
emphasizes measurement-based quality improvement (QI) and systems change. The aim of First STEPS is
to improve rates of EPSDT (Early and Periodic Screening, Diagnosis, and Treatment) services required for
children enrolled in MaineCare by promoting the Bright Futures curriculum adopted by the State of
Maine as the EPSDT standard of care. First STEPS also focuses on incorporating Patient-Centered
Medical Home (PCMH) principles into child-serving primary care practices. In selecting EPSDT-related
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practice improvement topics for each of the three phases of First STEPS, IHOC engaged child health
stakeholders in Maine to identify areas of concern and gaps in care. While Maine ranked 4th overall in
the 2011 Commonwealth Fund State Scorecard on Child Health System Performance, Maine’s rankings
on specific Scorecard indicators revealed the following opportunities for improvement:
•
•
•
•
•

41st in immunization rates
14th in developmental screening
13th in preventive dental care
13th in healthy weight
11th in preventive medical care i

As a CHIPRA-funded project, recruitment for First STEPS was targeted to practices serving a high volume
(>1000) of children enrolled in Maine’s Medicaid and CHIP ii programs (collectively known as MaineCare)
and to the pediatric practices participating in Maine’s Multi-Payer Patient Centered Medical Home
(PCMH) Pilot. A total of 28 practices iii from across the state participated in one or more of the three
topic-focused First STEPS phases:
•
•
•

Phase I: Childhood and Adolescent Immunizations
Phase II: Developmental and Autism Screening
Phase II: Healthy Weight and Oral Healthiv

Each phase of First STEPS ran approximately nine months long and included two day-long learning
sessions where participating practices came together to share ideas, progress, challenges, and
successes. Content experts presented information in a variety of formats during these interactive
learning sessions. Between the two learning sessions were contiguous monthly action periods during
which practices implemented Plan-Do-Study-Act (PDSA) cycles, collected and reported specific data, met
with their QI coaches and practice teams, and attended monthly webinars. Practices had access to their
QI coaches, the Director of Child Health Quality Improvement at Quality Counts, and additional staff for
data support and other needs throughout each of the phases. The QI coaches were also provided with
resources and guidance through Coaches’ Calls and communications with a QI consultant and other First
STEPS personnel.
Prior to the first learning session of each phase, practices identified their multi-disciplinary teams
consisting of a physician champion and nursing, clinical support, and administrative staff. During this
preparation stage, practices met with their assigned Quality Improvement (QI) coach, completed a prelearning session Office System Survey, began to develop their Aim statements, and participated in
baseline data collection to support evaluation. Practices that participated fully in any of the First STEPS
phases were eligible to earn Maintenance of Certification (MOC) credit at no charge to the providers. In
i

Securing a Healthy Future: The Commonwealth Fund State Scorecard on Child Health System Performance, 2011
For more information about CHIP, visit http://www.medicaid.gov/Medicaid-CHIP-Program-Information/ByTopics/Childrens-Health-Insurance-Program-CHIP/Childrens-Health-Insurance-Program-CHIP.html
iii
These 28 practices collectively serve more than 30,000 children enrolled in MaineCare which is equivalent to
approximately one-quarter of the total number of MaineCare-eligible children in the state.
iv
First STEPS Charter Document 2012 available at http://www.mainequalitycounts.org/page/2-700/mechipdocuments.
ii
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order to meet MOC requirements, practices submitted monthly data related to well-defined measures
and participated in analysis of practice-level and state-level results throughout the duration of the
learning collaborative. First STEPS also required that practices share data generated in support of their
practice improvement changes and PDSA cycles, and participate in data collection for the First STEPS
evaluation plan.

METHODS
First STEPS follows key principles of the IHI learning collaborative model including team formation, aimsetting, selecting and testing changes, and using measures of change in rapid Plan-Do-Study-Act (PDSA)
cycles.4 Emphasizing quantitative measures of change depends on measure selection and data collection
and reporting throughout the planning, implementation, and evaluation stages, including:
•
•
•
•

National or state benchmarks and baseline rates for overall project target-setting
Practice-level baseline rates for development of QI Aim statements
Periodic assessments to track progress during rapid PDSA cycles and set/adjust interim goals
Pre- and post-intervention rates for overall project evaluation

Selecting Quality Measures
The PQMP developed a set of criteria for evaluating measures during the group’s periodic reviews of the
CHIPRA Core Set. Based on the extent to which each of the existing and proposed measures meet these
criteria, the PQMP makes recommendations for adoption, retirement, or revision of measures in the
CHIPRA Core Set. The validity and reliability of the measure is evaluated for scientific acceptability, and
feasibility of collecting and reporting the measure is determined based on the number of States
currently reporting on the measure and the data sources utilized. Additional criteria include the
importance of the measure related to the measure topic, such as prevalence or incidence, cost and
utilization, and recent performance at the State or health plan level. The ability to improve performance
on the measure is also a consideration.5 Child health quality measures were selected for each of the
three First STEPS phases based on similar criteria, including relevance to the QI topic and project
objectives; availability of baseline data; and feasibility of collecting the data from participating
practices. v Alignment with measure sets for state and national initiatives was an additional and
important consideration. Based on a review of available immunization measures, feedback from
stakeholders, and IHOC’s overall objective to test CHIPRA measures, IHOC selected CHIPRA and
additional immunization measures for Phase I data collection and reporting, presented in Table 2.

v

As of December 2013, Maine successfully calculated 18 of the 26 CHIPRA Core Set measures for inclusion in one
or more of the State of Maine’s CHIP Annual Reports to CMS for Federal Fiscal Years 2010, 2011, and 2012.
However, due to challenges with calculating the measures using administrative data (i.e., data from claims and
eligibility systems), Maine has not yet reported to CMS any of the three CHIPRA Childhood and Adolescent
Immunization measures. Despite the inability to calculate accurate rates for the CHIPRA immunization measures
on a statewide basis, IHOC included the CHIPRA immunization measures on its list of First STEPS Phase I measures
due to stakeholder agreement that the measures are actionable and meaningful and based on their alignment with
national quality measurement initiatives including HEDIS and Meaningful Use Stage 2.
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Table 2. First STEPS Phase I Immunization Measures
Childhood Immunization Status
The percentage of children who turned 2 years of age during the measurement year and
received the following vaccine doses on or before their 2nd birthday:
 4 DTaP (diphtheria-tetanus-acellular pertussis)
 3 IPV (inactivated polio vaccine)
 1 MMR (measles-mumps-rubella)
 3 HiB (haemophilus influenzae type B)
 3 Hep B (hepatitis B)
 1 VZV (varicella)
 4 PCV (pneumococcal conjugate vaccine)
 1 Hep A (hepatitis A)
 2 or 3 RV (rotavirus)
 2 Influenza (seasonal flu)

Alignment
NCQA/HEDIS (CIS)
CHIPRA (CIS)
Meaningful Use
NQF #0038

Immunizations by 6 Years of Age
The percentage of children who turned 6 years of age during the measurement year and
received the following vaccine doses on or before their 6th birthday:
 2 MMR (measles-mumps-rubella)
 2 VZV (varicella)
 5 DTaP (diphtheria-tetanus-acellular pertussis)
 4 IPV (inactivated polio vaccine)

Alignment
IHOC

Immunization Status for Adolescents
The percentage of adolescents who turned 13 years of age during the measurement year and
received the following vaccine doses on or before their 13th birthday:
 1 MCV (meningococcal conjugate vaccine)
 1 Tdap OR 1 Td (tetanus-diphtheria-acellular pertussis booster OR tetanusdiphtheria booster)

Alignment
NCQA/HEDIS (IMA)
CHIPRA (IMA)
NQF #1407

HPV for Female and Male Adolescents
The percentage of adolescents who turned 13 years of age and received the following vaccine
doses on or between their 9th and 13th birthdays:
 3 HPV (human papillomavirus vaccine)

Alignment
NCQA/HEDIS (HPV)
CHIPRA (HPV)
NQF #1959

Influenza Immunization
The percentage of children aged 6 months and older seen for a visit between October 1 and
March 31 who received an influenza immunization OR who reported previous receipt of an
influenza immunization.

Alignment
AMA-PCPI
Meaningful Use
NQF #0041
Federal ACO #14

Abbreviations
AMA-PCPI
American Medical Association-Physician Consortium on Performance Improvement
ACO
Accountable Care Organization
NQF
National Quality Forum
NCQA
National Committee on Quality Assurance
HEDIS
Healthcare Effectiveness Data and Information Set

Selecting the Data Source
One of the most significant planning and implementation challenges for First STEPS Phase I was selecting
optimal data sources based on criteria IHOC identified as necessary to support the needs of the quality
improvement initiative, namely that a data source must produce reports inclusive of all vaccines in the
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First STEPS Phase I measures, for all children regardless of payer, for the correct age ranges, and for
specific practices participating in First STEPS. The reports must be generated frequently and
consistently, and they must reflect almost real-time changes in rates based on rapid cycle quality
improvement. Importantly, the reports must be understandable by practice teams so that they can use
them to track their progress. Efforts were also made to select data sources that would place minimal
burden on the practice teams (e.g., existing data within an EHR or registry system) vi. Four potential data
sources were evaluated based on these criteria, including Electronic Health Record (EHR) systems,
administrative (claims and eligibility) data systems, the National Immunization Survey data, and data
from the State’s Immunization Information System (II). A summary of their characteristics is presented in
Table 3.
Table 3. Characteristics of Potential Data Sources and Reporting Features

Rates are calculated…
…based on CHIPRA birth
date cut-off and dose
counts
…for all vaccines in the
First STEPS immunization
measures
…accurately and
consistently for a specific
provider or practice
…for all patients in a
practice, regardless of
payer
…on demand and in
close to real-time for
monthly PDSA cycles
…that are reflective of QI
efforts so that progress
can be seen quickly

Registry Data from State of Maine’s
Immunization Information System

Administrative Data

Survey Data

Maine Integrated
Health Management
System (MIHMS)

Nat’l Immunization
Survey (NIS)

AFIX
Reports

Existing
IIS Reports

IHOC
IIS Reports

Yes

No

No

No

Yes

Yes

No

No

No

Yes

No

No

Yes

Yes

Yes

No

No

Yes

Yes

Yes

No

No

No

Yes

Yes

No

No

No

Yes

Yes

Electronic Health Record (EHR) Systems
While using data from an Electronic Health Record (EHR) system may seem ideal for generating practicelevel reports, several barriers existed in leveraging this data for First STEPS Phase I. Although 53%
percent of pediatric practices in Maine reported the use of an EHR to some extent5, not all practices use
EHRs to enter immunization dose data. Even when immunization data exists within the EMR
consistently, IHOC learned that not all EMRs can generate reports and for those that do have reporting
functions, the associated reports are not designed to analyze the data according to the CHIPRA measure
vi

Due to technical challenges in calculating measures consistently and accurately across all the different EHRs
employed by First STEPS practices, most of the data collection relied on manual chart review processes. However,
the majority of immunization data collected for First STEPS Phase I was derived from the State of Maine’s
Immunization Information System (IIS).
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specifications. The time, effort, and cost required to develop new EHR reports to align with CHIPRA
measure specifications is substantial and the effort would need to be replicated for each of the many
different EHRs employed by the First STEPS practices. Therefore, IHOC did not pursue the use of EHR
data for First STEPS Phase I.
Administrative Data
As with most measures in the CHIPRA Core Set, CHIPRA immunization measures are designed for state
Medicaid and CHIP programs to voluntarily report rates to CMS on a statewide, aggregate basis only for
the population of children insured by Medicaid or CHIP.6 The specifications for the CHIPRA immunization
measures reflect this level of reporting and define data analysis methods primarily for use with
administrative data (i.e., Medicaid claims and eligibility systems) with a measurement look-back period
of one year. Using an administrative data set is beneficial because it typically provides a complete set of
data for the Medicaid population and can easily identify the continuous eligibility requirements needed
to build the denominator.vii However, the decision to expand the First STEPS target population to all
children in Maine regardless of payer appeared to preclude data from one or more claims systems as a
viable, reliable source for measure calculation. Depending on claims data alone can depict an
incomplete assessment of quality because claims data excludes both the uninsured population as well as
services that are prone to inaccurate or incomplete billing processes, such as immunizations.6 Indeed,
analysis conducted by IHOC in 2012 found that the Maine Integrated Health Management Systems
(MIHMS) claims data do not capture a significant portion of immunization doses delivered to MaineCare
members, likely due to inconsistent billing practices. Another barrier to using administrative data to
calculate CHIPRA immunization measures is the need for complete historical claims data for vaccine
doses from previous years. This level of historical data may not always be available or maintained
adequately in databases. Patients in the denominator may have received vaccines in previous years that
weren’t paid for by Medicaid; therefore, these doses will not exist in the Medicaid administrative data
set and will not count towards the calculated rate even if the child received all the required doses in
time.
First STEPS required a method for collecting and reporting measures at the practice level and for all
children regardless of insurer. Furthermore, the frequency of data collection for monthly PDSA cycles
was dependent on a quick turnaround time that could not be achieved using data from a claims system.
Because of these barriers, IHOC did not pursue administrative data as a source for First STEPS reporting.
National Immunization Survey (NIS)
Sponsored by the Centers for Disease Control and Prevention (CDC) beginning in 1994, the National
Immunization Survey (NIS) is used to assess progress towards national immunization goals for children
and adolescents based on vaccine schedule recommendations from the Advisory Committee on
vii

The CHIPRA Technical Specifications Manual also provides instructions for applying a “hybrid” method for
calculating these measures. With the hybrid method, a sample is drawn from the entire eligible population and the
numerator is built using either administrative data or evidence from the medical record such as a note indicating
the vaccine type and administration date or a certificate of immunization prepared by an authorized health care
provider. This method would most likely be used in conjunction with a “chart review” process for individual
practices and is not conducive to calculating statewide rates for the entire Medicaid population.
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Immunization Practices (ACIP). Established in 1993 under Section 222 of the Public Health Service Act
(42 U.S.C. § 2l7a), the ACIP is comprised of medical and public health experts and consumers who work
with professional organizations—including the American Academy of Pediatrics (AAP), the American
Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG),
and the American College of Physicians (ACP)—to develop recommendations for childhood, adolescent,
and adult vaccine schedules. The ACIP’s recommended schedules are reviewed annually by the Director
of the CDC and, once approved, are published as the official CDC immunization recommendations in the
Morbidity and Mortality Weekly Report (MMWR). viii The NIS is a telephone survey followed by a mailed
survey to immunization providers, with a target population of children between the ages of 19 and 35
months living in the United States at the time of the survey. The NIS data are helpful when looking at
state and national trends and when looking at how a State is doing in comparison to other States. The
NIS data are also used by local public health departments to identify pockets of low immunization rates
which can inform decisions about where to target outreach programs. IHOC used NIS data to initially
identify immunizations as an area in need of improvement in Maine. However, the NIS data are not
useful for practice-level reporting or quality improvement because the rates are not specific to
individual patients, providers, or practices, and because the results are generated on an annual basis
only.
State of Maine’s Immunization Information System (IIS)—ImmPact
The national Childhood Immunization Initiative was formed in the wake of the United States measles
epidemic of 1989 to 1991 which claimed the lives of 130 children and saw more than 55,000
documented cases of measles among our children. The initiative set a goal to increase childhood
immunization status to 90% of the population, and comprised a five-part strategy to achieve this goal by
1996. Components of this multi-pronged approach included raising vaccine awareness among health
professionals and the public, increasing community participation, building private-public partnerships,
and increased monitoring of coverage levels and suveillance of disease.7 One example of early work to
address these goals was the development of automated Immunization Information Systems (IIS).
Funded initially through the Robert Wood Johnson Foundation, a requirement of these IIS grant projects
was to engage the full participation of public and private health care communities in development and
implementation of the IIS.7 Today, IIS is defined by the CDC as “confidential, computerized, populationbased systems that collect and consolidate vaccination data from vaccination providers and provide
important tools for designing and sustaining effective immunization strategies.”8 The IIS allows providers
to screen a child’s immunization status at every visit, create parent reminder notices for upcoming
vaccinations and recall notices for overdue vaccinations, and generate population-based immunization
coverage rates (ICR). 7 In addition to these functions, most IIS can also be used for vaccine inventory
management, recording of product data, and reporting of adverse events.9
Recognizing the benefits of IIS utilization in achieving optimal immunization status for children living in
the US, a Healthy People 2020 objective is that 95% of children less than 6 years of age will have
immunization records in a fully operational, population-based IIS by 2020.8 A major approach to
reaching this goal is promoting the benefits of the IIS to providers to increase participation and
viii

http://www.cdc.gov/vaccines/acip/recs/index.html
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therefore increase the number of children whose immunization records exist within an IIS.8 Health plans
have also recognized the value of IIS in attaining optimal immunization status for their covered
population. For example, a cost-benefit analysis of employing an IIS within a managed care plan with
480,000 members resulted in an $8.06 return on every $1.00 spent on immunization quality
measurement activities utilizing IIS data in place of chart review or claims data.9 In addition, measures
calculated using IIS data showed significant increases in demonstrated childhood and adolescent
immunization rates when compared to rates calculated with claims data only. For example, the HEDIS
childhood immunization combination rate was 35.09% based on claims data and 88.80% based on IIS
data; the HEDIS adolescent immunization combination rate was 2.82% based on claims data and 74.62%
based on IIS data. This analysis also found that providers must perceive data as accurate and reliable
before buying in to the use of data for practice improvement and accountability initiatives. Furthermore,
the use of IIS data to calculate immunization quality measures helps ameliorate concerns about data; for
example, that claims data are not reflective of actual rates or quality of care. 9
Based on local provider feedback that is consistent with national perspectives on the topic, IHOC learned
that the IIS operated by the Maine CDC, known as ImmPact, is considered by many providers to be the
gold standard of dose-level immunization data for children in Maine. A major benefit of ImmPact as a
data source is its connectivity with most immunization providers including schools, hospitals, emergency
departments, and physician offices. A child’s immunization status in ImmPact reflects doses
administered and recorded by any provider who enters per-patient doses in ImmPact. While vaccine
doses are not recorded in ImmPact for every child, the Maine Immunization Program (MIP) estimates
that 70% of children statewide have dose-level data recorded in ImmPact. Therefore, the information
viewed in ImmPact is a more complete record of the child’s immunization status than, for example, a
practice-based Electronic Health Record (EHR) which typically only includes doses administered at that
practice.
When considering ImmPact as a source of data for First STEPS, IHOC discovered some limitations despite
its benefits. While most child-serving practices use ImmPact to enter patient-level dose data and all
Maine practices manage their vaccine inventory through ImmPact, double data entry is still considered a
major burden on providers and in some cases, a barrier to full participation (i.e., using the IIS to enter
patient-level dose data as opposed to only using the required vaccine inventory management for statesupplied vaccines). Many child-serving practices in Maine enter vaccine doses exclusively in ImmPact
and not in their own EHR, thereby reducing the burden of double-data entry while still having access to
the child’s immunization record. However, some practices enter doses in both their EHR and ImmPact
which is not only cumbersome for providers but also promotes human error and can result in
incomplete, inaccurate, or untimely record-keeping in one or both systems. Some health systems and
practices have elected to not enter patient-level dose data into ImmPact until the double entry issue is
resolved, which means that doses administered for patients at those practices are not currently
captured in ImmPact ix. IHOC also learned through its work with practices that failure to properly manage

ix

The Maine Immunization Program is currently working with health systems on technical solutions that will allow
ImmPact to receive immunization data directly from practice EHRs, thereby removing the barrier of double entry
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a provider’s patient list in ImmPact leads to inaccurate reports since patients that are inactive at the
practice are still included in the rates. In order to improve the quality of their data, several First STEPS
practices engaged in major efforts to identify and remove inactive patients from their ImmPact lists.
These efforts are time and resource intensive and in some cases required hiring temporary staff to
complete the task.
Despite the challenges described above, IHOC recognized ImmPact as a viable source of quality data for
First STEPS Phase I reporting. Selecting ImmPact as a data source also aligned with the good
immunization practices promoted by First STEPS Phase I and aligned with national initiatives regarding
increasing the use of IIS to improve coordinated care across immunization providers; reduce both
missed opportunities and duplicated vaccines; and use data to support immunization surveillance and
quality improvement efforts to raise immunization rates.
The Maine Immunization Program’s AFIX Reports
The Comprehensive Clinical Assessment Software Application (CoCASA), sponsored by the US Centers
for Disease Control and Prevention, is used to assess immunization practices within a clinic, private
practice, or any other environment where immunizations are provided. The CoCASA software is
designed for use in conjunction with the US CDC’s AFIX (Assess, Feedback, Incentives, eXchange)
strategy employed by public health and disease prevention programs across the country. The Maine
CDC’s Maine Immunization Program (MIP) leverages CoCASA and immunization dose data within
ImmPact to support their statewide AFIX program which includes site visits, surveys, and reports. The
AFIX assessment is performed on every primary care practice in the state on a two year cycle, and
annually for the largest practices. In order to perform these assessments, MIP conducts a manual or
electronic process to generate a rate report for each practice. The manual process is utilized for
practices that do not use ImmPact to report vaccine dose data for their patients. In these cases, MIP
conducts a site visit and records dose data for 100% of patients aged 24-35 months (or a cap of 100
charts, whichever is greater) for analysis via CoCASA. An electronic assessment is conducted for
practices that utilize ImmPact to report dose data. In these cases, MIP identifies 100% of the practice’s
clients aged 24-35 months within ImmPact for analysis via CoCASA. The CoCASA rates do not include
“late Up To Date” doses (i.e., doses that are given after the child’s 2nd birthday but that are clinically
valid according to ACIP-recommended alternate or catch up schedules). The AFIX reports are generated
on an annual or biannual basis only and while they do generate rates for all children regardless of payer,
they do not include rates for all vaccines in the First STEPS measures. For these reasons, the AFIX reports
could not be employed for First STEPS reporting.
ACIP Immunization Coverage Reports (ICR)
The existing Immunization Coverage Reports (ICR) in ImmPact—known as “ACIP” reports—are
generated using an analytical tool called the Forecaster which employs a complex algorithm to apply
ACIP vaccine recommendations including alternate schedules, catch up schedules, and grace periods.
The ICR cannot be used to calculate CHIPRA measures because although CHIPRA measures follow
and increasing the availability of dose data within ImmPact. MIP and a major health system began to pilot this
technical solution in December 2013. Results were not available as of the time of the writing of this report.
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standard ACIP-recommended vaccine schedules, the CHIPRA specifications employ a simpler dose count
and a stricter birthdate cut-off, among other differences.
One example of the variations between CHIPRA and ACIP specifications is the minimum time interval
between vaccine doses for multiple-dose series. For example, for IPV (inactivated polio vaccine), ACIP
recommends a minimum interval of four weeks between the first and second IPV dose, and a minimum
of six months between the 2nd and 3rd dose. The ACIP report counts only valid doses based on these
time intervals, whereas the CHIPRA specification for IPV reads "At least three IPV vaccinations, with
different dates of service on or before the child's second birthday..." Therefore, doses administered
fewer than four weeks apart are counted in the rate for the CHIPRA measure but they are not counted
in the rate for the ACIP report.
Another variation is seen in how rates are calculated for the rotavirus (RV) vaccine. ACIP recommends a
minimum interval of four weeks between RV doses and also recommends that the vaccine not be
administered to children older than eight months (32 weeks) of age. x The CHIPRA specification for RV
counts doses that have been administered fewer than four weeks apart as well as doses administered
after eight months of age, whereas the ACIP report does not include any of those doses in the
numerator of the rate.
One of the most significant differences between these specifications is that—similar to the AFIX reports
generated by MIP for practice assessments described previously—CHIPRA uses the child’s birthdate as
an anchor for the rate and only counts doses that were given before or on the child’s 2nd birthday (for
Childhood Immunization Status) or 13th birthday (for Immunization Status of Adolescents). In contrast,
the ACIP report uses the date of the report as an anchor and counts all clinically-valid, “Late Up To Date”
doses in the rate.

Using Data from the IIS to Calculate Practice-level CHIPRA Measures
To meet the ongoing reporting needs of First STEPS Phase I, IHOC leveraged registry data from the
State's IIS, ImmPact, to generate timely and useable practice-level reports based on CHIPRA and
additional immunization measures. For practices that had been using the IIS for patient-level dose data
entry xi for at least one year prior to the start of the initiative (19 of the 22 practices participating in First
STEPS Phase I), data from the IIS were analyzed and displayed in run charts. The remaining three
practices used a manual chart review process to generate data for analysis and display in run charts.
Prior to the start of Phase I, IHOC investigated existing reporting functions within the IIS as described
above, and determined that unique reports would need to be developed in order to calculate rates
based on the CHIPRA measure specifications. The existing IIS reports calculate rates based on the
American College of Immunization Practices’ (ACIP) recommended vaccine schedules and include
provisions for due-date grace periods and alternate or catch up schedules which are not included in the
CHIPRA measure specifications. In addition, the CHIPRA immunization measures include additional
x

http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm?s_cid=rr6002a1_e#Tab1
In Maine, all practices must use the IIS to order and manage vaccine inventory as part of the Vaccines for
Children program, but they are not required to enter patient-level dose data into the IIS.
xi
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childhood and adolescent vaccines and also specify a simpler dose count when determining vaccine
doses to be included in the rate.
IHOC partnered with the Maine Immunization Program (MIP) and the Office of Information Technology,
both at the State of Maine’s Department of Health and Human Services, to make technical changes to
the IIS that would allow practices to produce on-demand reports based on CHIPRA measure
specifications. These efforts involved the development and testing of complex technical changes to the
IIS itself as well as frequent data analysis and measure specification review to ensure that technical
changes met IHOC immunization measure requirements. The Muskie School of Public Service at the
University of Southern Maine provided the data analysis and quality measure expertise for this work
with technical support and project management from IHOC staff at the Office of Information
Technology.
Making technical changes to the IIS proved more complicated than originally anticipated and depended
on specialized skill sets high in demand and not always readily available. Delays in completing the
technical changes necessitated a work-around reporting process to support the needs of First STEPS
Phase I. This manually-driven process involved extracting dose data from the IIS for each participating
practice, running the data through customized analytical reports, and compiling the aggregate data into
run charts that were easy for practices to read and understand. These run charts were produced by
IHOC staff at the Muskie School and the Office of Information Technology in collaboration with the
Maine Immunization Program (the owner of the IIS) on a monthly basis for eight months during the
learning initiative and then quarterly to support ongoing QI for another two years until technical
changes to the IIS were completed and made available to providers in June 2013.
While the manual reports successfully met the data needs for First STEPS Phase I, IHOC faced challenges
when transitioning the reporting process to practices, primarily related to messaging to providers. For
example, rates in the manual reports did not match perfectly with rates in the ImmPact reports for a
variety of technical reasons explained in detail in the Frequently Asked Questions document (Appendix
A). This was confusing to practices and raised new concerns about the quality of the data which required
extensive outreach to overcome. Providers also needed training on how to generate the IHOC Quick Pick
reports independently; this education is currently ongoing. As a first step, IHOC partnered with MIP to
develop an instructional document (Appendix B) which has been distributed to providers through
multiple venues. To build on face-to-face relationship-building promoted through First STEPS, members
of the IHOC team will co-present with MIP technical staff on the IHOC Quick Picks during regional
provider trainings occurring the summer of 2014.
Despite challenges, generating manual reports provided unexpected opportunities to fine-tune the IHOC
Quick Pick technical changes prior to their completion, based on lessons learned about the complexities
of calculating CHIPRA measures using registry data. In addition, during this time period, CMS published
changes to the CHIPRA childhood and adolescent immunization measures which were incorporated into
the IHOC Quick Pick technical changes prior to their release into production.
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IHOC Quick Pick Reports
Immunization measures included in First STEPS Phase I can now be generated by providers using the
“IHOC Quick Pick” buttons found on the ImmPact Immunization Coverage Report (ICR) Criteria Page. The
IHOC Quick Picks generate reports based on the CHIPRA childhood and adolescent immunizations
measures plus an additional measure for children at 6 years of age. One of two types of reports is
generated by the IHOC Quick Picks, based on user selection:
1. Immunization Coverage Rates: An aggregate report for the selected practice that includes
denominator, numerator, and rate for each of the single vaccines as well as denominator,
numerator, and combination rate for all vaccines included in the measure.
2. Patient Listing: A client level report for the corresponding Immunization Coverage Rates report
for the selected practice, which shows a list of clients who counted for (Up To Date) the
combination rate for all vaccines in the selected IHOC Quick Pick as well as a list of clients who
counted against (not Up To Date) that combination rate, with the overdue vaccine specified.

NAME OF IMMUNIZATION REPORT USING DATA FROM IMMPACT
VACCINES
INCLUDED

AFIX
MIP

ACIP
ImmPact

IHOC At Age 2
ImmPact

IHOC At Age 6
ImmPact

DTaP









Polio









MMR









Hib







HepB







Varicella







Pneumococcal







HepA



RV



Flu



IHOC At Age 13
ImmPact



Meningococcal



TdaP/Td



HPV



RESULTS
The First STEPS Phase I Evaluation Report produced by the Muskie School presented findings related to
this work including those described in this report.3 Analysis of pre- and post-intervention First STEPS
Phase I Office System Surveys showed an increase among participating practices in the use of 22 out of
31 recommended immunization-related office procedures. Statistically significant changes included
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using recall and reminder systems for children due or past due for vaccines; reviewing and updating
dose data in the IIS; and routinely reviewing practice vaccination rates. Interviews with practices
revealed that two of the most effective office procedures for improving immunization rates were using
data in the IIS to review and update patient records, and having data to track progress on a monthly
basis. In addition to office system changes, significant increases in immunization rates were achieved.
Overall immunization rates among practices participating in First STEPS Phase I increased from baseline
by 5.1 percentage points at 12 months after project initiation, surpassing the Phase I goal to improve
immunization rates by 4 percentage points within one year of project initiation. Ongoing increases were
found several months after the end of Phase I as practices continued the QI work and as office system
changes were fully adopted. At 15 months after project initiation, overall immunization rates among
participating practices increased from baseline by 7.1 percentage points.

DISCUSSION
A qualitative analysis of immunization programs with sustained high immunization coverage rates
between 2000 and 2005, conducted for the National Center for Immunization and Respiratory Diseases,
found that the most frequently-cited aspects of effective initiatives were relationship-building,
partnership development, and implementation and use of IIS. Respondents from both participant
groups—internal partners (e.g., immunization program staff) and external partners (e.g., healthcare
providers)—touted the benefits of IIS utilization for improving immunization rates beyond simple data
collection. Both groups noted that education and communication efforts aimed at healthcare providers
were especially important, as was infrastructure development related to promotion of medical home
principles. Identifying and promoting a shared goal of healthy children was key to achieving increased
and sustained immunization rates. External partners stated that providers must see the potential value
to them when engaging in quality improvement partnerships, especially those that require additional
actions or effort on their part. Finally, the use of data—particulary data from an IIS—was acknowledged
by both groups as an integral aspect of sustained high immunization coverage rates.10
Similar lessons were learned during IHOC regarding the importance of cross-organizational partnerships
and the use of the State’s IIS. Through First STEPS planning and implementation, important publicprivate partnerships were established that proved critical to the success of the project by identifying
shared goals, developing common messaging, promoting the use of data and a standard set of quality
measures, and helping to overcome data collection and reporting challenges. Partnerships with groups
such as the Maine Immunization Coalition and the Maine Vaccine Board resulted in common messaging
and shared goals so that the quality improvement work could continue past the end of the grant. In
addition, the Maine Health Management Coalition adopted the CHIPRA immunization measures for their
Pathways to Excellence (PTE) public reporting program, thereby enhancing alignment of efforts and
creating additional emphasis on periodic, practice-level reporting for these measures.
The collaborative leadership provided by the Medical Director of Quality Counts for Kids was highly
effective in emphasizing shared goals to promote sustainable results. In fact, the Medical Director was
recognized by the US CDC as the 2014 Maine Childhood Immunization Champion for her work on First
STEPS. Furthermore, IHOC’s approach was aligned with the U.S. Centers for Disease Control and
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Prevention’s (CDC) Assessment, Feedback, Incentives, and eXchange (AFIX) xii QI program which is
employed by MIP, the owner of the State’s IIS. This alignment helped gain internal support for the
technical changes being made to the IIS through IHOC funds despite scarce human resources, and
promoted dissemination of the new reporting functions to all users of the IIS regardless of their
participation in First STEPS, and which is expected to continue as part of MIP’s daily operations.
Maine faced important challenges while implementing practice-level CHIPRA and other immunization
measures for First STEPS Phase I. Making technical changes to the IIS proved more complicated than
originally anticipated and required a specialized skill set that was not always readily available. Issues
with data quality and differences among available rate reports created confusion and inhibited provider
trust in the data, which in turn made it more difficult to promote the value of using data for QI
initiatives. Finding effective ways to explain the differences in quality measures and how to use different
rate reports was challenging but vital when addressing these issues. IHOC identified the following
lessons learned regarding the importance of selecting quality measures and data sources:
• Measures cannot be meaningfully operationalized without reliable methods for collecting,
calculating, and reporting the data that are not unduly burdensome to providers
• Increasing provider use of a fully-operational Immunization Information System is an effective
approach to data-driven QI aimed at increasing immunization coverage rates
• Providers must trust the data in order to buy in to utilizing data for QI
To support the use of quality measures and data, IHOC emphasizes the importance of data support and
clear messaging to providers:
• Differences in measure specifications and rate calculations
• How and when to use each type of data or quality measure
• How to read, interpret, and use practice-level reports for QI efforts
Despite challenges, important achievements include completing technical changes to the IIS reporting
functions; improving patient-level dose data entry and management by participating providers;
promoting the use of standardized, practice-level reports for QI activities; and improving office system
procedures related to raising immunization rates for children and adolescents. IHOC also used feedback
from its stakeholders to identify questions and develop messaging in response to the needs of providers
related to long-term adoption of office system changes and the use of data for ongoing quality
improvement.
Finally, IHOC’s experience in leveraging IIS data to calculate CHIPRA measures at the practice-level in a
cross-organizational quality improvement effort to improve immunization rates resulted in lessons
learned about cross-organizational collaboration:
• Bringing unassociated practices together in a joint learning collaborative fosters statewide
momentum towards attaining common goals and creates potential for greater overall results (i.e.,
increasing provider participation in the State’s IIS improves everyone’s data).
• Collaborative leadership promotes effective cross-organizational partnerships which result in
common messaging and alignment of efforts towards sustained improvements (i.e., PTE adoption of
CHIPRA measures).
xii

http://www.cdc.gov/vaccines/programs/afix/index.html
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